Our recent publication compares genetic diversity in commercially available AAV products using three different sequencing methods. Read Here
Quantifying DNA point mutations in commercially available AAV reporter vectors.
Rebecca Rose, David J. Nolan, Jonathan A. DaRoza, Sanford L. Boye, Susanna L. Lamers
ASPR/BARDA awards $500 million for Project NextGen technologies that advance innovative next-generation vaccine and therapeutics platforms. BioInfoExperts is among the recipients, with $4 million to provide genomic sequencing of COVID-19. For more information visit: https://medicalcountermeasures.gov/nextgen/
Cloudticity provides BIE with protocols that assist BIE in protecting against cybersecurity threats to ensure our technologies meet the compliance requirements of today and tomorrow.
BIE is aggressively entering the gene therapy manufacturing industry where they will genetically characterize viral vector-based products, like rAAVs. By providing methods that improve quality control, BIE will assist these companies in taking novel therapeutics to the market faster and with fewer side effects.
Dr. Chenzhong Li of Tulane University and Susanna Lamers, CEO of BioInfoExperts, talk about their breakthrough technologies on WWNO’s NPR broadcast of “Out to Lunch”. The show was recorded live over lunch at NOLA Pizza in the NOLA Brewing Taproom. Out to Lunch is hosted by finance professor Peter Ricchiuti and the recorded podcast, called “Science” can be found online at https://itsneworleans.com/2022/04/27/science/
The “BIE Underwrites Genome Sequencing” (B.U.G.S) funding will provide whole pathogen genome sequencing and analysis for up to 35 de-identified pathogen samples. Two awards will be granted to selected individuals working in the fields of infectious disease/infection control/industrial hygiene.
Whole genome sequencing (WGS) of pathogens improves the understanding of outbreaks, treatments, and the evolution of infectious disease. We have developed automated approaches and easy-to-use HIPPA-compliant software that removes the analytical barriers to incorporating WGS into current workflows.
Please include in your submission a 1-2 page description of the following:
- Institution: Size, location, and any other distinguishing features about the setting where the samples were/will be collected (e.g. underserved, urban, rural).
- Samples: Type of pathogen, tissue collected, storage conditions (either already collected or prospective collection)
- Yourself: Your role and what you hope to learn from this project
Please send your application to info@bioinfox.com on or before 8/15/2023
First round selections will be made by 9/15/2023, with final award letter on or before 10/15/2023.
Contact us at info@bioinfox.com for additional information.
(This award is for research purposes only and is not intended for diagnostics. The award is limited to applicants in the United States. Additional conditions will be negotiated prior to award)
Louisiana businesses, nonprofits and universities are making important advances in life sciences research and application.
BioInfoExperts is funded by the National Science Foundation Small Business Innovation Research program to develop a patented software platform, FoxSeq, that investigates pathogen transmission and evolution. This technology can be used to improve infection control, surveillance and patient outcomes. The company consults on bioinformatics, automated workflows, experimental design and laboratory research.
More than 80 startups funded by the U.S. National Science Foundation are creating technology solutions to enhance the detection and treatment of COVID-19.
Earlier this year, the Small Business Innovation Research/Small Business Technology Transfer program solicited proposals for the development of new technologies, products, processes and services with the potential to impact the nation’s and world’s ability to respond to the COVID-19 crisis. To date, NSF has awarded more than $15 million to dozens of startups that are putting their technology to work to address this global pandemic.
“Startups nationwide responded with creativity and a diversity of experiences to create innovative technology solutions in the COVID-19 crisis,” said Andrea Belz, director for the Division of Industrial Innovation and Partnerships. “NSF-funded solutions have the potential to make a significant impact in the fight against COVID and future pandemic threats.”
Visit the website for a full list of awards to small businesses, including BioInfoExperts, working to address the COVID-19 crisis.